Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Mar;65(3):1023–1031. doi: 10.1128/iai.65.3.1023-1031.1997

Purification and in vitro activities of rabbit platelet microbicidal proteins.

M R Yeaman 1, Y Q Tang 1, A J Shen 1, A S Bayer 1, M E Selsted 1
PMCID: PMC175084  PMID: 9038312

Abstract

Recent in vitro studies have demonstrated that rabbit platelets release a small, cationic antimicrobial protein in response to thrombin stimulation under physiological conditions (M. R. Yeaman, S. M. Puentes, D. C. Norman, and A. S. Bayer, Infect. Immun. 60:1202-1209, 1992). This observation prompted our present investigation, focused on determining the array of antimicrobial proteins contained within rabbit platelets and their in vitro activity against common bloodstream pathogens. A group of small (6.0- to 9.0-kDa), cationic proteins with in vitro antimicrobial activity was purified from whole and thrombin-stimulated rabbit platelets by gel filtration and reversed-phase high-performance liquid chromatography. Purified proteins in micromolar concentrations (10 to 40 microg/ml) exerted in vitro microbiostatic and/or microbicidal activities against Staphylococcus aureus, Escherichia coli, and Candida albicans in a dose-dependent manner. The antimicrobial activities of proteins purified from rabbit platelet acid extracts were generally inversely related to pH, with maximal activity observed at pH 5.5. In contrast, the predominant protein isolated from thrombin-stimulated rabbit platelets, though biochemically and microbiologically similar to proteins extracted by acid, exhibited antimicrobial activities which were modestly enhanced at pH 7.2 compared with pH 5.5. Amino acid compositional analyses in combination with molecular mass determinations suggest that the majority of these proteins are distinct molecules not derived from a single common precursor. Collectively, these data indicate that rabbit platelets contain proteins which exert potent in vitro antimicrobial activity against bacterial and fungal pathogens which commonly invade the bloodstream. Moreover, several of these proteins were released from platelets stimulated with thrombin under physiological conditions and exerted potent antimicrobial activities in physiological pH ranges. These observations support the hypothesis that platelets serve an important role in host defense against infection, via localized release of antimicrobial proteins in response to stimuli associated with tissue injury or microbial colonization.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calderone R. A., Rotondo M. F., Sande M. A. Candida albicans endocarditis: ultrastructural studies of vegetation formation. Infect Immun. 1978 Apr;20(1):279–289. doi: 10.1128/iai.20.1.279-289.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Carroll S. F., Martinez R. J. Antibacterial peptide from normal rabbit serum. 2. Compositional microanalysis. Biochemistry. 1981 Oct 13;20(21):5981–5987. doi: 10.1021/bi00524a009. [DOI] [PubMed] [Google Scholar]
  3. Carroll S. F., Martinez R. J. Antibacterial peptide from normal rabbit serum. 3. Inhibition of microbial electron transport. Biochemistry. 1981 Oct 13;20(21):5988–5994. doi: 10.1021/bi00524a010. [DOI] [PubMed] [Google Scholar]
  4. Carroll S. F., Martinez R. J. Antibacterial peptide from normal rat serum. 1. Isolation from whole serum, activity, and microbicidal spectrum. Biochemistry. 1981 Oct 13;20(21):5973–5981. doi: 10.1021/bi00524a008. [DOI] [PubMed] [Google Scholar]
  5. Clawson C. C. Platelet interaction with bacteria. 3. Ultrastructure. Am J Pathol. 1973 Mar;70(3):449–471. [PMC free article] [PubMed] [Google Scholar]
  6. Clawson C. C., Rao G. H., White J. G. Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am J Pathol. 1975 Nov;81(2):411–420. [PMC free article] [PubMed] [Google Scholar]
  7. Clawson C. C., White J. G. Platelet interaction with bacteria. I. Reaction phases and effects of inhibitors. Am J Pathol. 1971 Nov;65(2):367–380. [PMC free article] [PubMed] [Google Scholar]
  8. Clawson C. C., White J. G. Platelet interaction with bacteria. II. Fate of the bacteria. Am J Pathol. 1971 Nov;65(2):381–397. [PMC free article] [PubMed] [Google Scholar]
  9. Czuprynski C. J., Balish E. Interaction of rat platelets with Listeria monocytogenes. Infect Immun. 1981 Jul;33(1):103–108. doi: 10.1128/iai.33.1.103-108.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dankert J., van der Werff J., Zaat S. A., Joldersma W., Klein D., Hess J. Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect Immun. 1995 Feb;63(2):663–671. doi: 10.1128/iai.63.2.663-671.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Darveau R. P., Blake J., Seachord C. L., Cosand W. L., Cunningham M. D., Cassiano-Clough L., Maloney G. Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity. J Clin Invest. 1992 Aug;90(2):447–455. doi: 10.1172/JCI115880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Donaldson D. M., Tew J. G. beta-Lysin of platelet origin. Bacteriol Rev. 1977 Jun;41(2):501–513. doi: 10.1128/br.41.2.501-513.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Drake T. A., Pang M. Effects of interleukin-1, lipopolysaccharide, and streptococci on procoagulant activity of cultured human cardiac valve endothelial and stromal cells. Infect Immun. 1989 Feb;57(2):507–512. doi: 10.1128/iai.57.2.507-512.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Drake T. A., Pang M. Staphylococcus aureus induces tissue factor expression in cultured human cardiac valve endothelium. J Infect Dis. 1988 Apr;157(4):749–756. doi: 10.1093/infdis/157.4.749. [DOI] [PubMed] [Google Scholar]
  15. Drake T. A., Rodgers G. M., Sande M. A. Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits. J Clin Invest. 1984 Jun;73(6):1750–1753. doi: 10.1172/JCI111383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Durack D. T., Beeson P. B. Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br J Exp Pathol. 1972 Feb;53(1):44–49. [PMC free article] [PubMed] [Google Scholar]
  17. Durack D. T., Beeson P. B. Experimental bacterial endocarditis. II. Survival of a bacteria in endocardial vegetations. Br J Exp Pathol. 1972 Feb;53(1):50–53. [PMC free article] [PubMed] [Google Scholar]
  18. Durack D. T., Beeson P. B., Petersdorf R. G. Experimental bacterial endocarditis. 3. Production and progress of the disease in rabbits. Br J Exp Pathol. 1973 Apr;54(2):142–151. [PMC free article] [PubMed] [Google Scholar]
  19. Durack D. T. Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions. J Pathol. 1975 Feb;115(2):81–89. doi: 10.1002/path.1711150204. [DOI] [PubMed] [Google Scholar]
  20. Feldman C., Kallenbach J. M., Levy H., Thorburn J. R., Hurwitz M. D., Koornhof H. J. Comparison of bacteraemic community-acquired lobar pneumonia due to Streptococcus pneumoniae and Klebsiella pneumoniae in an intensive care unit. Respiration. 1991;58(5-6):265–270. doi: 10.1159/000195943. [DOI] [PubMed] [Google Scholar]
  21. Harwig S. S., Ganz T., Lehrer R. I. Neutrophil defensins: purification, characterization, and antimicrobial testing. Methods Enzymol. 1994;236:160–172. doi: 10.1016/0076-6879(94)36015-4. [DOI] [PubMed] [Google Scholar]
  22. JAGO R., JACOX R. F. Cellular source and charcter of a heatstable bactericidal property associated with rabbit and rat platelets. J Exp Med. 1961 Apr 1;113:701–711. doi: 10.1084/jem.113.4.701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Johnson F. B., Donaldson D. M. Purification of staphylocidal beta-lysin from rabbit serum. J Bacteriol. 1968 Sep;96(3):589–595. doi: 10.1128/jb.96.3.589-595.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kahn R. A., Flinton L. J. The relationship between platelets and bacteria. Blood. 1974 Nov;44(5):715–721. [PubMed] [Google Scholar]
  25. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  26. Lehrer R. I., Rosenman M., Harwig S. S., Jackson R., Eisenhauer P. Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods. 1991 Mar 21;137(2):167–173. doi: 10.1016/0022-1759(91)90021-7. [DOI] [PubMed] [Google Scholar]
  27. Maisch P. A., Calderone R. A. Adherence of Candida albicans to a fibrin-platelet matrix formed in vitro. Infect Immun. 1980 Feb;27(2):650–656. doi: 10.1128/iai.27.2.650-656.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Mandell G. L., Hook E. W. The interaction of platelets, Salmonella, and mouse peritoneal macrophages. Proc Soc Exp Biol Med. 1969 Nov;132(2):757–759. doi: 10.3181/00379727-132-34304. [DOI] [PubMed] [Google Scholar]
  29. Miragliotta G., Lafata M., Jirillo E. Anti-bacterial activity mediated by human platelets. Agents Actions. 1988 Dec;25(3-4):401–406. doi: 10.1007/BF01965049. [DOI] [PubMed] [Google Scholar]
  30. Ockenhouse C. F., Magowan C., Chulay J. D. Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to the CD36 surface receptor in vitro. J Clin Invest. 1989 Aug;84(2):468–475. doi: 10.1172/JCI114188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Rosenfeld S. I., Looney R. J., Leddy J. P., Phipps D. C., Abraham G. N., Anderson C. L. Human platelet Fc receptor for immunoglobulin G. Identification as a 40,000-molecular-weight membrane protein shared by monocytes. J Clin Invest. 1985 Dec;76(6):2317–2322. doi: 10.1172/JCI112242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Scheld W. M., Valone J. A., Sande M. A. Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest. 1978 May;61(5):1394–1404. doi: 10.1172/JCI109057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Selsted M. E., Harwig S. S. Purification, primary structure, and antimicrobial activities of a guinea pig neutrophil defensin. Infect Immun. 1987 Sep;55(9):2281–2286. doi: 10.1128/iai.55.9.2281-2286.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Selsted M. E. Investigational approaches for studying the structures and biological functions of myeloid antimicrobial peptides. Genet Eng (N Y) 1993;15:131–147. doi: 10.1007/978-1-4899-1666-2_6. [DOI] [PubMed] [Google Scholar]
  35. Selsted M. E., Szklarek D., Lehrer R. I. Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun. 1984 Jul;45(1):150–154. doi: 10.1128/iai.45.1.150-154.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Selsted M. E., Szklarek D., Lehrer R. I. Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun. 1984 Jul;45(1):150–154. doi: 10.1128/iai.45.1.150-154.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Smith-Erichsen N. Serial determinations of platelets, leucocytes and coagulation parameters in surgical septicemia. Scand J Clin Lab Invest Suppl. 1985;178:7–14. [PubMed] [Google Scholar]
  38. Sullam P. M., Drake T. A., Sande M. A. Pathogenesis of endocarditis. Am J Med. 1985 Jun 28;78(6B):110–115. doi: 10.1016/0002-9343(85)90373-0. [DOI] [PubMed] [Google Scholar]
  39. Sullam P. M., Frank U., Yeaman M. R., Täuber M. G., Bayer A. S., Chambers H. F. Effect of thrombocytopenia on the early course of streptococcal endocarditis. J Infect Dis. 1993 Oct;168(4):910–914. doi: 10.1093/infdis/168.4.910. [DOI] [PubMed] [Google Scholar]
  40. Sullam P. M., Payan D. G., Dazin P. F., Valone F. H. Binding of viridans group streptococci to human platelets: a quantitative analysis. Infect Immun. 1990 Nov;58(11):3802–3806. doi: 10.1128/iai.58.11.3802-3806.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Tew J. G., Roberts R. R., Donaldson D. M. Release of beta-lysin from platelets by thrombin and by a factor produced in heparinized blood. Infect Immun. 1974 Jan;9(1):179–186. doi: 10.1128/iai.9.1.179-186.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Viscoli C., Bruzzi P., Castagnola E., Boni L., Calandra T., Gaya H., Meunier F., Feld R., Zinner S., Klastersky J. Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer. 1994;30A(4):430–437. doi: 10.1016/0959-8049(94)90412-x. [DOI] [PubMed] [Google Scholar]
  43. Weksler B. B., Nachman R. L. Rabbit platelet bactericidal protein. J Exp Med. 1971 Nov 1;134(5):1114–1130. doi: 10.1084/jem.134.5.1114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wu T., Yeaman M. R., Bayer A. S. In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates. Antimicrob Agents Chemother. 1994 Apr;38(4):729–732. doi: 10.1128/aac.38.4.729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Yeaman M. R., Ibrahim A. S., Edwards J. E., Jr, Bayer A. S., Ghannoum M. A. Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro. Antimicrob Agents Chemother. 1993 Mar;37(3):546–553. doi: 10.1128/aac.37.3.546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Yeaman M. R., Norman D. C., Bayer A. S. Platelet microbicidal protein enhances antibiotic-induced killing of and postantibiotic effect in Staphylococcus aureus. Antimicrob Agents Chemother. 1992 Aug;36(8):1665–1670. doi: 10.1128/aac.36.8.1665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Yeaman M. R., Norman D. C., Bayer A. S. Staphylococcus aureus susceptibility to thrombin-induced platelet microbicidal protein is independent of platelet adherence and aggregation in vitro. Infect Immun. 1992 Jun;60(6):2368–2374. doi: 10.1128/iai.60.6.2368-2374.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Yeaman M. R., Puentes S. M., Norman D. C., Bayer A. S. Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein. Infect Immun. 1992 Mar;60(3):1202–1209. doi: 10.1128/iai.60.3.1202-1209.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Yeaman M. R., Soldan S. S., Ghannoum M. A., Edwards J. E., Jr, Filler S. G., Bayer A. S. Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis. Infect Immun. 1996 Apr;64(4):1379–1384. doi: 10.1128/iai.64.4.1379-1384.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Yeaman M. R., Sullam P. M., Dazin P. F., Norman D. C., Bayer A. S. Characterization of Staphylococcus aureus-platelet binding by quantitative flow cytometric analysis. J Infect Dis. 1992 Jul;166(1):65–73. doi: 10.1093/infdis/166.1.65. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES